T1	Participants 43 123	female patients undergoing curative adjuvant irradiation following breast cancer
T2	Participants 574 668	50 patients submitted to curative adjuvant irradiation following surgery for mammary carcinoma
T3	Participants 724 800	patients with irradiations of the thoracic wall and the regional lymph nodes
